Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report

Saved in:
Bibliographic Details
Published in:Lung Cancer: Targets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301677737967617
collection WordPress RSS
FRELIP Feed Integration
container_title Lung Cancer: Targets and Therapy
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58409
institution FRELIP
journal_source_facet Lung Cancer: Targets and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_auth Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_full Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_fullStr Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_full_unstemmed Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_short Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
title_sort response to selpercatinib in a ccdc6-ret lung adenocarcinoma with an acquired novel ret p.l730_g731insl after progression on pralsetinib: a case report
topic Respiratory Diseases
General
Respiratory Diseases
url https://www.dovepress.com/response-to-selpercatinib-in-a-ccdc6-ret-lung-adenocarcinoma-with-an-a-peer-reviewed-fulltext-article-LCTT